Screening for cognitive toxicity of anticholinergic drugs

I. R. Katz, W. H. Greenberg, G. A. Barr, C. Garbarino, P. Buckley, D. Smith

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Impairment of memory by muscarinic anticholinergic drugs has been demonstrated with a variety of agents using both acute administration in normal volunteers and chronic treatment in patients. Cognitive toxicity must be considered in the evaluation of the risks versus the benefits of psychopharmacologic treatment. The relationship between serum levels of anticholinergic drugs measured by radioreceptor assay and performance on the Buschke Selective Reminding Test were investigated to develop strategies for identifying patients with drug-related cognitive impairment. The radioreceptor assay may be of value in screening for patients at high risk for cognitive toxicity. However, there appears to be no alternative to careful longitudinal evaluation of learning and memory in patients after appropriate trial modifications of their medication regimens to identify patients with drug-related impairment.

Original languageEnglish (US)
Pages (from-to)323-326
Number of pages4
JournalJournal of Clinical Psychiatry
Volume46
Issue number8
StatePublished - Oct 31 1985

Fingerprint

Cholinergic Antagonists
Drug-Related Side Effects and Adverse Reactions
Radioligand Assay
Pharmaceutical Preparations
Cholinergic Agents
Healthy Volunteers
Learning
Therapeutics
Serum

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Katz, I. R., Greenberg, W. H., Barr, G. A., Garbarino, C., Buckley, P., & Smith, D. (1985). Screening for cognitive toxicity of anticholinergic drugs. Journal of Clinical Psychiatry, 46(8), 323-326.

Screening for cognitive toxicity of anticholinergic drugs. / Katz, I. R.; Greenberg, W. H.; Barr, G. A.; Garbarino, C.; Buckley, P.; Smith, D.

In: Journal of Clinical Psychiatry, Vol. 46, No. 8, 31.10.1985, p. 323-326.

Research output: Contribution to journalArticle

Katz, IR, Greenberg, WH, Barr, GA, Garbarino, C, Buckley, P & Smith, D 1985, 'Screening for cognitive toxicity of anticholinergic drugs', Journal of Clinical Psychiatry, vol. 46, no. 8, pp. 323-326.
Katz IR, Greenberg WH, Barr GA, Garbarino C, Buckley P, Smith D. Screening for cognitive toxicity of anticholinergic drugs. Journal of Clinical Psychiatry. 1985 Oct 31;46(8):323-326.
Katz, I. R. ; Greenberg, W. H. ; Barr, G. A. ; Garbarino, C. ; Buckley, P. ; Smith, D. / Screening for cognitive toxicity of anticholinergic drugs. In: Journal of Clinical Psychiatry. 1985 ; Vol. 46, No. 8. pp. 323-326.
@article{ea5d135402a44458b697cef332fa1b04,
title = "Screening for cognitive toxicity of anticholinergic drugs",
abstract = "Impairment of memory by muscarinic anticholinergic drugs has been demonstrated with a variety of agents using both acute administration in normal volunteers and chronic treatment in patients. Cognitive toxicity must be considered in the evaluation of the risks versus the benefits of psychopharmacologic treatment. The relationship between serum levels of anticholinergic drugs measured by radioreceptor assay and performance on the Buschke Selective Reminding Test were investigated to develop strategies for identifying patients with drug-related cognitive impairment. The radioreceptor assay may be of value in screening for patients at high risk for cognitive toxicity. However, there appears to be no alternative to careful longitudinal evaluation of learning and memory in patients after appropriate trial modifications of their medication regimens to identify patients with drug-related impairment.",
author = "Katz, {I. R.} and Greenberg, {W. H.} and Barr, {G. A.} and C. Garbarino and P. Buckley and D. Smith",
year = "1985",
month = "10",
day = "31",
language = "English (US)",
volume = "46",
pages = "323--326",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "8",

}

TY - JOUR

T1 - Screening for cognitive toxicity of anticholinergic drugs

AU - Katz, I. R.

AU - Greenberg, W. H.

AU - Barr, G. A.

AU - Garbarino, C.

AU - Buckley, P.

AU - Smith, D.

PY - 1985/10/31

Y1 - 1985/10/31

N2 - Impairment of memory by muscarinic anticholinergic drugs has been demonstrated with a variety of agents using both acute administration in normal volunteers and chronic treatment in patients. Cognitive toxicity must be considered in the evaluation of the risks versus the benefits of psychopharmacologic treatment. The relationship between serum levels of anticholinergic drugs measured by radioreceptor assay and performance on the Buschke Selective Reminding Test were investigated to develop strategies for identifying patients with drug-related cognitive impairment. The radioreceptor assay may be of value in screening for patients at high risk for cognitive toxicity. However, there appears to be no alternative to careful longitudinal evaluation of learning and memory in patients after appropriate trial modifications of their medication regimens to identify patients with drug-related impairment.

AB - Impairment of memory by muscarinic anticholinergic drugs has been demonstrated with a variety of agents using both acute administration in normal volunteers and chronic treatment in patients. Cognitive toxicity must be considered in the evaluation of the risks versus the benefits of psychopharmacologic treatment. The relationship between serum levels of anticholinergic drugs measured by radioreceptor assay and performance on the Buschke Selective Reminding Test were investigated to develop strategies for identifying patients with drug-related cognitive impairment. The radioreceptor assay may be of value in screening for patients at high risk for cognitive toxicity. However, there appears to be no alternative to careful longitudinal evaluation of learning and memory in patients after appropriate trial modifications of their medication regimens to identify patients with drug-related impairment.

UR - http://www.scopus.com/inward/record.url?scp=0021863694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021863694&partnerID=8YFLogxK

M3 - Article

C2 - 2862135

AN - SCOPUS:0021863694

VL - 46

SP - 323

EP - 326

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 8

ER -